Draft Genome Sequence of Klebsiella pneumoniae KGM-IMP216 Harboring blaCTX-M-15, blaDHA-1, blaTEM-1B, blaNDM-1, blaSHV-28, and blaOXA-1, Isolated from a Patient in Lebanon

Genome Announcements
Sima TokajianDavid A Coil

Abstract

We present the draft genome of highly drug-resistant Klebsiella pneumoniae KGM-IMP216, isolated from a urine sample collected from a patient in Lebanon. The draft genome sequence consisted of 77 contigs, including a combined 5,731,500 bases with 57% G+C content.

References

Jan 9, 1998·Infectious Disease Clinics of North America·G A Jacoby
Oct 15, 2005·Clinical Microbiology Reviews·David L Paterson, Robert A Bonomo
Jul 4, 2006·American Journal of Infection Control·David L Paterson
Feb 12, 2008·BMC Genomics·Ramy K AzizOlga Zagnitko
Oct 18, 2011·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
May 23, 2012·Journal of Infection in Developing Countries·Rima I El-HerteSouha S Kanj
May 29, 2012·Journal of Infection and Public Health·Rima I El-HerteGeorge F Araj
Oct 3, 2012·PloS One·Andrew TrittAaron E Darling
Jan 15, 2013·The Journal of Antimicrobial Chemotherapy·E P BarantsevichN Woodford
Apr 23, 2014·Antimicrobial Agents and Chemotherapy·Andreas SchlüterLaurent Poirel
Apr 30, 2014·Antimicrobial Agents and Chemotherapy·Alessandra CarattoliHenrik Hasman

❮ Previous
Next ❯

Citations

Mar 19, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Tania Nawfal DagherJean-Marc Rolain

❮ Previous
Next ❯

Datasets Mentioned

BETA
LJOI00000000

Software Mentioned

RAST
PlasmidFinder

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.